Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Hepatitis C viral quasispecies.

Gómez J, Martell M, Quer J, Cabot B, Esteban JI.

J Viral Hepat. 1999 Jan;6(1):3-16. Review.

PMID:
10847126
2.

Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver.

Cabot B, Martell M, Esteban JI, Sauleda S, Otero T, Esteban R, Guàrdia J, Gómez J.

J Virol. 2000 Jan;74(2):805-11.

3.
4.

Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.

Pawlotsky JM, Pellerin M, Bouvier M, Roudot-Thoraval F, Germanidis G, Bastie A, Darthuy F, Rémiré J, Soussy CJ, Dhumeaux D.

J Med Virol. 1998 Apr;54(4):256-64.

PMID:
9557291
5.

Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients.

Gretch DR, Polyak SJ, Wilson JJ, Carithers RL Jr, Perkins JD, Corey L.

J Virol. 1996 Nov;70(11):7622-31.

7.

Wide range of quasispecies diversity during primary hepatitis C virus infection.

Herring BL, Tsui R, Peddada L, Busch M, Delwart EL.

J Virol. 2005 Apr;79(7):4340-6.

8.

Deep sequencing and phylogenetic analysis of variants resistant to interferon-based protease inhibitor therapy in chronic hepatitis induced by genotype 1b hepatitis C virus.

Sato M, Maekawa S, Komatsu N, Tatsumi A, Miura M, Muraoka M, Suzuki Y, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Uetake T, Inoue T, Sato T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N.

J Virol. 2015 Jun;89(11):6105-16. doi: 10.1128/JVI.03127-14. Epub 2015 Mar 25.

9.

Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma.

Maggi F, Fornai C, Vatteroni ML, Giorgi M, Morrica A, Pistello M, Cammarota G, Marchi S, Ciccorossi P, Bionda A, Bendinelli M.

J Gen Virol. 1997 Jul;78 ( Pt 7):1521-5.

PMID:
9225024
11.

Quasispecies analysis in hepatitis C virus infection by fluorescent single strand conformation polymorphism.

Peters T, Schlayer HJ, Hiller B, Rösler B, Blum H, Rasenack J.

J Virol Methods. 1997 Feb;64(1):95-102.

PMID:
9029534
12.

[HCV genome variability in acute and chronic viral hepatitis C].

Iushchuk ND, Klimova EA, Znoĭko OO, Gadzhikulieva MM, Il'ina EN, Iashina TL, Malyshev NA, Tsyganova EV.

Ter Arkh. 2009;81(4):47-55. Russian.

PMID:
19514422
13.

Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C.

Kurosaki M, Enomoto N, Marumo F, Sato C.

Virology. 1994 Nov 15;205(1):161-9.

PMID:
7975211
14.

Analysis of hepatitis C virus quasispecies populations by temperature gradient gel electrophoresis.

Lu M, Funsch B, Wiese M, Roggendorf M.

J Gen Virol. 1995 Apr;76 ( Pt 4):881-7.

PMID:
9049334
15.

Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C.

Gerotto M, Resti M, Dal Pero F, Migliorato I, Alberti A, Bortolotti F.

Infection. 2006 Apr;34(2):62-5.

PMID:
16703294
16.

Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C.

Grahovac B, Bingulac-Popovic J, Vucelic B, Hrstic I, Ostojic R, Drazic V, Balija M, Grgicevic D.

J Clin Virol. 2001 Jan;20(1-2):85-9.

PMID:
11163588
17.

Quasispecies of hepatitis C virus in serum and in three different parts of the liver of patients with chronic hepatitis.

Sakai A, Kaneko S, Honda M, Matsushita E, Kobayashi K.

Hepatology. 1999 Aug;30(2):556-61.

PMID:
10421668
18.

Characterization of Hepatitis C Virus (HCV) Envelope Diversification from Acute to Chronic Infection within a Sexually Transmitted HCV Cluster by Using Single-Molecule, Real-Time Sequencing.

Ho CKY, Raghwani J, Koekkoek S, Liang RH, Van der Meer JTM, Van Der Valk M, De Jong M, Pybus OG, Schinkel J, Molenkamp R.

J Virol. 2017 Feb 28;91(6). pii: e02262-16. doi: 10.1128/JVI.02262-16. Print 2017 Mar 15.

19.

Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy.

Pawlotsky JM, Germanidis G, Frainais PO, Bouvier M, Soulier A, Pellerin M, Dhumeaux D.

J Virol. 1999 Aug;73(8):6490-9.

20.

Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection.

Chambers TJ, Fan X, Droll DA, Hembrador E, Slater T, Nickells MW, Dustin LB, Dibisceglie AM.

J Virol. 2005 Mar;79(5):3071-83.

Supplemental Content

Support Center